drugset / Trial / NCT07472192

Comparative Study for Facial Scar Remodeling Using Fractional Carbon Dioxide Laser Combined With PDRN Versus Fractional CO₂ Laser

NCT07472192

Phase 2 Recruiting 36 enrolled Misr University for Science and Technology
RandomizedParallel-groupTriple-blindTreatment

Summary

Facial scars are frequently deemed unpleasant and can profoundly impact a patient's psychological health. This study compares the effectiveness, safety, and capacity to speed up scar healing in the maxillofacial region between fractional carbon dioxide (CO₂) laser therapy alone and polydeoxyribonucleotide (PDRN) combined with CO₂ laser therapy.

Timeline

Start
2026-03-01
Primary completion
2026-07-01
Completion
2026-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Polydeoxyribonucleotide Unknown Other

Indications

No indication recorded.